GRIO


COHEN-SOLAL

Pr Martine COHEN-SOLAL

Comité scientifique du GRIO


Présentation > Les membres du Comité Directeur > Pr Martine COHEN-SOLAL > Publications

PUBLICATIONS RÉCENTES


Sermet-Gaudelus I, Nove-Josserand R, Loeille GA, Dacremont G, Souberbielle JC, Fritsch J, Laurans M, Moulin P, Cortet B, Salles JP, Ginies JL, Guillot M, Perez-Martin S, Ruiz JC, Montagne V, Cohen-Solal M, Cormier C, Garabédian M, Mallet E; et la Fédération française des centres de ressource et de compétence en mucoviscidose. Recommandations pour la prise en charge de la déminéralisation osseuse dans la mucoviscidose. Arch Pediatr. 2008 Mar;15(3):301-12. Epub 2008 Mar 5. French.

Ea HK, Monceau V, Camors E, Cohen-Solal M, Charlemagne D, Lioté F. Annexin V overexpression increased joint chondrocyte apoptosis induced by basic calcium phosphate crystals. Ann Rheum Dis. 2008 Jan 24. [Epub ahead of print]

Pelat C, Van Pottelbergh I, Cohen-Solal M, Ostertag A, Kaufman JM, Martinez M, de Vernejoul MC. Complex segregation analysis accounting for GxE of bone mineral density in European pedigrees selected through a male proband with low BMD.
Ann Hum Genet. 2007 Jan;71(Pt 1):29-42.

Saintier D, Khanine V, Uzan B, Ea HK, de Vernejoul MC, Cohen-Solal ME. Estradiol inhibits adhesion and promotes apoptosis in murine osteoclasts in vitro. J Steroid Biochem Mol Biol. 2006 Jun;99(4-5):165-73. Epub 2006 Apr 18.

Demerjian-Somogyi N, Palazzo E, Cohen-Solal M. Osteoporosis in patients with inflammatory bowel disease. Joint Bone Spine. 2005;72(5):354-6

Karsak M, Cohen-Solal M, Freudenberg J, Ostertag A, Morieux C, Kornak U, Essig J, Erxlebe E, Bab I, Kubisch C, de Vernejoul MC, Zimmer A. Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum Mol Genet. 2005 15;14(22):3389-96

Ferrari SL, Deutsch S, Baudoin C, Cohen-Solal M, Ostertag A, Antonarakis SE, Rizzoli R, de Vernejoul MC. LRP5 gene polymorphisms and idiopathic osteoporosis in men. Bone. 2005;37(6):770-5

Saidenberg-Kermanac'h N, Corrado A, Lemeiter D, deVernejoul MC, Boissier MC, Cohen-Solal ME. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. Bone. 2004;35(5):1200-7

Saidenberg-Kermanac'h N, Bessis N, Lemeiter D, de Vernejoul MC, Boissier MC, Cohen-Solal M. Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in collagen-induced arthritis. J Clin Immunol. 2004;24(4):370-8

Cunningham J, Sprague SM, Cannata-Andia J, Coco M, Cohen-Solal M, Fitzpatrick L, Goltzmann D, Lafage-Proust MH, Leonard M, Ott S, Rodriguez M, Stehman-Breen C, Stern P, Weisinger J; Osteoporosis Work Group. Osteoporosis in chronic kidney disease. Am J Kidney Dis. 2004;43(3):566-71

Saidenberg-Kermanac'h N, Cohen-Solal M, Bessis N, De Vernejoul MC, Boissier MC. Role for osteoprotegerin in rheumatoid inflammation. Joint Bone Spine. 2004;71(1):9-13

Cohen-Solal M, Baudoin C, Joly F, Vahedi K, D'Aoust L, De Vernejoul MC, Messing B. Osteoporosis in patients on long-term home parenteral nutrition a longitudinal study. J Bone Miner Res. 2003;18(11):1989-94

Saintier D, Burde MA, Rey JM, Maudelonde T, de Vernejoul MC, Cohen-Solal ME. 17beta-estradiol downregulates beta3-integrin expression in differentiating and mature human osteoclasts. J Cell Physiol. 2004;198(2):269-76

Urena P, Bernard-Poenaru O, Ostertag A, Baudoin C, Cohen-Solal M, Cantor T, de Vernejoul MC. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant. 2003;18(11):2325-31

Pecheur I, Peyruchaud O, Serre CM, Guglielmi J, Voland C, Bourre F, Margue C, Cohen-Solal M, Buffet A, Kieffer N, Clezardin P. Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB J. 2002;16(10):1266-8

Saidenberg Kermanac'h N, Bessis N, Cohen-Solal M, De Vernejoul MC, Boissier MC. Osteoprotegerin and inflammation. Eur Cytokine Netw. 2002;13(2):144-53

Urena P, Bernard-Poenaru O, Cohen-Solal M, de Vernejoul MC. Plasma bone-specific alkaline phosphatase changes in hemodialysis patients treated by alfacalcidol. Clin Nephrol. 2002;57(4):261-73

Baudoin C, Cohen-Solal ME, Beaudreuil J, De Vernejoul MC. Genetic and environmental factors affect bone density variances of families of men and women with osteoporosis. J Clin Endocrinol Metab. 2002;87(5):2053-9

Ramalho AC, Couttet P, Baudoin C, Morieux C, Graulet AM, de Vernejoul MC, Cohen-Solal ME. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures. Eur Cytokine Netw. 2002;13(1):39-45

Levy P, Levy E, Audran M, Cohen-Solal M, Fardellone P, Le Parc JM. The cost of osteoporosis in men the French situation. Bone. 2002 Apr;30(4):631-6

Cohen-Solal M. Strontium overload and toxicity impact on renal osteodystrophy. Nephrol Dial Transplant. 2002;17 Suppl 2:30-4

Cohen-Solal ME, Augry F, Mauras Y, Morieux C, Allain P, de Vernejoul MC. Fluoride and strontium accumulation in bone does not correlate with osteoid tissue in dialysis patients. Nephrol Dial Transplant. 2002;17(3):449-54

Ramalho AC, Jullienne A, Couttet P, Graulet AM, Morieux C, de Vernejoul MC, Cohen-Solal ME. Effect of oestradiol on cytokine production in immortalized human marrow stromal cell lines. Cytokine. 2001 21;16(4):126-30

Bernard-Poenaru O, Roux C, Blanque R, Gardner C, de Vemejoul MC, Cohen-Solal ME. Bone-resorbing cytokines from peripheral blood mononuclear cells after hormone replacement therapy a longitudinal study. Osteoporos Int. 2001;12(9):769-76

Fournier A, Cohen Solal ME, Oprisiu R, Choukroun G, Moriniere PH, Bouillon R. 7-84 PTH or aluminum antagonism in the resistance of uremic bone to the remodeling effect of endogenous PTH? Kidney Int. 2001;59(6):2375-6

Marie P, Debiais F, Cohen-Solal M, de Vernejoul MC. New factors controlling bone remodeling. Joint Bone Spine. 2000;67(3):150-6

Dernière mise à jour : 17-01-2017